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Abstract
We report the coexistence of Hb Camperdown [104 (G6) Arg  Ser] and °-thalassemia [39 (Gln  stop codon)]
in a nine-month-old Brazilian boy. He had a relatively more severe hypochromic and microcytic anemia in
comparison to his mother’s -thalassemia trait. His Hb Camperdown heterozygous father was clinically and
hematologically normal. To our knowledge, this is the first description of an association of °-thalassemia with Hb
Camperdown.
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Inherited hemoglobin disorders are the most common
single-gene diseases known, and approximately 1000 dif-
ferent mutant alleles have been identified, occurring widely
throughout the tropics (Old, 2003; Weatherall and Clegg,
2001; Zago and Costa, 1985). The well-defined forms of
hemoglobin disorders vary considerably within and be-
tween ethnic groups, and both ethnicity and environment
are important factors in the analysis of genotype/phenotype
correlations, as demonstrated by the clinical diversity of
-thalassemia (Thein, 2004).
Twenty-five years have elapsed since a mutation in
the -globin gene was first reported as the cause of
-thalassemia (Chang and Kan, 1979). Currently, almost
200 different mutations have been described which cause
beta-globin imbalance, leading to anemia of variable sever-
ity (Fonseca et al., 1998; Olivieri, 1999). The association of
thalassemia and structural hemoglobin variants produces a
wide spectrum of clinical and hematological outcomes,
ranging from severe to moderate microcytic hypochromic
anemia to no significant clinical alterations (Olivieri,
1999).
Although data on the extent of the diversity of hemo-
globin disorders in Brazil are incomplete (Old, 2003; Zago
and Costa, 1985; Fonseca et al., 1998; Araújo et al., 2003),
many -globin mutant alleles have been detected in pa-
tients from different Brazilian regions (Araújo et al., 2003;
Fonseca et al., 1998; Grignoli et al., 2000).
Herein we describe the co-inheritance of a rare hemo-
globin variant and -thalassemia in a Brazilian child.
A nine-month-old Brazilian boy was referred to the
Department of Diagnosis of Hemoglobin Disorders at the
“Hospital das Clínicas” of the São Paulo State University
School of Medicine because his mother was a carrier of
thalassemia minor. Blood samples of the child were sub-
mitted to routine hemoglobin electrophoresis and a subtle
change in the electrophoretic pattern was observed on cel-
lulose acetate, demonstrating a fast moving abnormality.
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Familial study was then undertaken. The propositus and
his father presented abnormal hemoglobin migration, i.e.,
faster than Hb A, on cellulose acetate, pH 8.9 (Figure 1),
and their blood migration patterns on citrate agar, pH 6.1,
were slightly different from that of Hb F. After isoelec-
trofocusing, the abnormal hemoglobin showed a migra-
tion pattern slightly more cathodic than Hb A, indicating a
decrease in the number of positive charges. Electrophore-
sis of the globin chain revealed a -chain variant with a
slower migration rate than that of the normal one (Figure
1). High Pressure Liquid Chromatography (HPLC) analy-
sis demonstrated a variant hemoglobin fraction character-
ized by concentration values of 83.5% and 49.6%, in the
propositus and his father, respectively, as well as a reten-
tion time of 1.26 minutes. Additionally, the propositus’
hematological profile - high RBC (red blood cell), low
MCV (mean cell volume), and raised Hb A2 - was strongly
suggestive of an interaction with the thalassemia trait (Ta-
ble 1).
The double mutation of -globin genes in the
propositus was subsequently confirmed by DNA sequenc-
ing of exon 2 of the -globin. DNA samples were isolated
from peripheral blood leucocytes. We used the primers de-
scribed by Kimura et al. (2003). PCR (polymerase chain re-
action) was performed with the upstream primer (P1)
5’-TCCTAAGCCAGTGCCAGAAG-3’ and the down-
stream primer (P5) 5’-TCATTCGTCTGTTTCCCATTC-
3’. Automatic backward and forward sequencing (ABI
DNA sequencer, model 377, Applied Biosystems, Foster
City, CA, USA) was performed with the upstream primer
() 5’-TTTGCTTCTGACACAACTG-3’ and the down-
stream primer (P5), using an ABI PRISM Big Dye Termi-
nator Cycle sequencing Kit. The propositus and his mother
were found to be heterozygous for a nonsense mutation: the
C  T substitution at the first nucleotide position of the 39th
codon, in exon 2 of the -globin gene, creates a stop codon
resulting in premature termination of the globin chain syn-
thesis. This -thalassemia mutation is common in the Med-
iterranean population and is also one of the most frequent
-globin mutations found in Brazil (Fonseca et al., 1998).
Another -globin gene mutation was detected in the
propositus and his father: the 104 (G6) arginine residue
was replaced by serine [beta 104(G6) Arg  Ser], resulting
in the variant Camperdown Hemoglobin (Hb Camper-
down). Therefore, the DNA sequence analysis of the -glo-
bin genes revealed the coexistence of °-thalassemia and
Hb Camperdown mutations in the propositus.
This is the first report of the co-occurrence of Hb Cam-
perdown and °-thalassemia. -thalassemia heterozygotes
manifest a typical clinical picture, characterized by mild
anemia, reduction in mean cell volumes and in mean cell
hemoglobin concentrations, elevated concentrations of
HbA2, altered erythrocyte morphology, and imbalance of
globin-chain synthesis with an alpha/beta ratio > 1 (Bianco
et al., 1977). Hb Camperdown is considered slightly unsta-
ble, resulting in a benign clinical course in heterozygous in-
dividuals (Wilkinson et al.; 1975; Blouquit et al., 1984;
Kister et al., 1989; Miranda et al., 1996). This hemoglobin
mutation leads to a slightly decreased molecular stability,
due to the positively charged residues lining the 12 inter-
face, where anionic cofactors bind to tetrameric hemoglo-
bin (Arnone, 1972). It was first described by Wilkinson et
al. (1975) in a woman of Maltese origin, and several other
carriers of this mutant hemoglobin were later described
originating from countries bordering the Mediterranean
Sea (Blouquit et al., 1984). Miranda et al. (1996) reported
the first case of Hb Camperdown in South America, in a
Brazilian woman of Italian descent. Hb Camperdown carri-
ers do not show significant clinical alterations.
The doubly heterozygous child described herein pre-
sented a relatively more pronounced hypochromic and
microcytic anemia in comparison with his mother’s -
thalassemia trait, while his Hb Camperdown heterozygous
father was clinically and hematologically normal. The
propositus also presented lower values of MCV and MCH
than those obtained by Bertuzzo et al. (1997) in 45 -
thalassemia carriers with the ° 39 mutation, ranging in age
from 16 to 66 years. The child’s follow-up will provide in-
formation for a better understanding of the clinical impact
of the interaction of heterozygosis for both -thalassemia
and Hb Camperdown.
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Figure 1 - Electrophoresis: (A) Alkaline electrophoresis: faster HbA mi-
gration in the propositus and his father. (B) Globin chain electrophoresis:
slower -chain migration (x) in the propositus and his father. Lanes: (1)
mother; (2) propositus; (3) father; (4) normal brother; (C) control, hetero-
zygous for sickle cell anemia.
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Table 1 - Molecular, biochemical and hematological data.
DNA sequence variation
 globin gene (exon 2)1
Propositus
[g. 115 C > T];
[g. 312 G > T]
Mother
[g. 115 C > T]
Father
[g. 312 G > T]
Brother
No mutation
Age 9 m 22 y 24 y nd2
Ht % 38.1 37.0 45.4 38.1
Hb g/dL 11.3 11.5 16.1 13.7
RBC 1012/L 6.81 5.90 5.63 4.94
MCV Fl 55.9 62.7 80.7 77.1
MCH Pg 16.6 19.5 28.5 27.7
HbA23 % 5.2 4.4 2.6 2.4
Hb x: Hb Camperdown3 % 83.5 absent 49.6 Absent
Hb F3 % 4.4 1.3 0 0
Reticulocytes % 1.3 2.2 1.3 1.9
1Analysis by ABI DNA sequencer, model 377, Applied Biosystems, Foster City, CA, USA. Nomenclature based on Human Database Mutation.
2n.d. - not determined data
3Quantification by HPLC, -thalassemia Short Program (Bio-Rad Laboratories, Hercules, CA, USA).
